documents
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
31 rows where docket_id = "FDA-2022-N-0002" and posted_year = 2023 sorted by posted_date descending
This data as json, CSV (advanced)
Suggested facets: subtype, posted_date, posted_date (date), comment_start_date (date), last_modified (date)
| id | agency_id | docket_id | title | document_type | subtype | posted_date ▲ | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2022-N-0002-0050 | FDA | None FDA-2022-N-0002 | New Animal Drugs; Approval of New Animal Drug Applications; Change of Sponsor | Rule | Final Rule | 2023-03-20T04:00:00Z | 2023 | 3 | 2023-03-20T04:00:00Z | 2023-03-20T13:29:00Z | 2023-05465 | 0 | 0 | 09000064857fdf5e | |
| FDA-2022-N-0002-0041 | FDA | None FDA-2022-N-0002 | FOI Summary oA 200-730 approved November 4 2022 | Supporting & Related Material | Background Material | 2023-03-17T04:00:00Z | 2023 | 3 | 2023-03-17T13:51:32Z | 0 | 0 | 09000064857cc6ec | |||
| FDA-2022-N-0002-0045 | FDA | None FDA-2022-N-0002 | FOI Summary sA 200-377 approved December 2 2022 | Supporting & Related Material | Background Material | 2023-03-17T04:00:00Z | 2023 | 3 | 2023-03-17T13:52:09Z | 0 | 0 | 09000064857cc6f1 | |||
| FDA-2022-N-0002-0040 | FDA | None FDA-2022-N-0002 | EAsN 141-450 approved December 23 2022 | Supporting & Related Material | Background Material | 2023-03-17T04:00:00Z | 2023 | 3 | 2023-03-17T13:51:25Z | 0 | 0 | 09000064857cc6eb | |||
| FDA-2022-N-0002-0043 | FDA | None FDA-2022-N-0002 | FOI Summary oN 141-566 approved December 8 2022 | Supporting & Related Material | Background Material | 2023-03-17T04:00:00Z | 2023 | 3 | 2023-03-17T13:51:46Z | 0 | 0 | 09000064857cc58a | |||
| FDA-2022-N-0002-0048 | FDA | None FDA-2022-N-0002 | FOI Summary sN 141-529 approved December 2 2022 | Supporting & Related Material | Background Material | 2023-03-17T04:00:00Z | 2023 | 3 | 2023-03-17T13:52:41Z | 0 | 0 | 09000064857cc6f4 | |||
| FDA-2022-N-0002-0049 | FDA | None FDA-2022-N-0002 | FONSI sN 141-450 approved December 2 2022 | Supporting & Related Material | Background Material | 2023-03-17T04:00:00Z | 2023 | 3 | 2023-03-17T13:52:59Z | 0 | 0 | 09000064857cc785 | |||
| FDA-2022-N-0002-0042 | FDA | None FDA-2022-N-0002 | FOI Summary oN 141-559 approved December 20 2022 | Supporting & Related Material | Background Material | 2023-03-17T04:00:00Z | 2023 | 3 | 2023-03-17T13:51:39Z | 0 | 0 | 09000064857cc589 | |||
| FDA-2022-N-0002-0044 | FDA | None FDA-2022-N-0002 | FOI Summary oN 141-567 approved November 14 2022 | Supporting & Related Material | Background Material | 2023-03-17T04:00:00Z | 2023 | 3 | 2023-03-17T13:52:01Z | 0 | 0 | 09000064857cc6ef | |||
| FDA-2022-N-0002-0047 | FDA | None FDA-2022-N-0002 | FOI Summary sN 141-450 approved December 23 2022 | Supporting & Related Material | Background Material | 2023-03-17T04:00:00Z | 2023 | 3 | 2023-03-17T13:52:34Z | 0 | 0 | 09000064857cc6f3 | |||
| FDA-2022-N-0002-0046 | FDA | None FDA-2022-N-0002 | FOI Summary sA 200-455 approved December 15 2022 | Supporting & Related Material | Background Material | 2023-03-17T04:00:00Z | 2023 | 3 | 2023-03-17T13:52:18Z | 0 | 0 | 09000064857cc780 | |||
| FDA-2022-N-0002-0039 | FDA | None FDA-2022-N-0002 | New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Applications; Change of Sponsor; Change of Sponsor Name and Address | Rule | Final Rule | 2023-03-10T05:00:00Z | 2023 | 3 | 2023-03-10T05:00:00Z | 2023-03-10T14:16:10Z | 2023-03649 | 0 | 0 | 090000648578b486 | |
| FDA-2022-N-0002-0031 | FDA | None FDA-2022-N-0002 | FOI Summary oN 141-564 approved July 28, 2022 | Supporting & Related Material | Background Material | 2023-03-09T05:00:00Z | 2023 | 3 | 2023-03-09T13:32:47Z | 0 | 0 | 090000648577904e | |||
| FDA-2022-N-0002-0021 | FDA | None FDA-2022-N-0002 | EA sN 141-348 approved July 18, 2022 | Supporting & Related Material | Background Material | 2023-03-09T05:00:00Z | 2023 | 3 | 2023-03-09T13:30:47Z | 0 | 0 | 090000648577897f | |||
| FDA-2022-N-0002-0024 | FDA | None FDA-2022-N-0002 | FOI Summary oA 200-724 approved July 19, 2022 | Supporting & Related Material | Background Material | 2023-03-09T05:00:00Z | 2023 | 3 | 2023-03-09T13:31:15Z | 0 | 0 | 09000064857789d2 | |||
| FDA-2022-N-0002-0029 | FDA | None FDA-2022-N-0002 | FOI Summary oN 141-462 approved September 6, 2022 | Supporting & Related Material | Background Material | 2023-03-09T05:00:00Z | 2023 | 3 | 2023-03-09T13:32:33Z | 0 | 0 | 09000064857789d5 | |||
| FDA-2022-N-0002-0032 | FDA | None FDA-2022-N-0002 | FOI Summary oN 141-565 approved August 11, 2022 | Supporting & Related Material | Background Material | 2023-03-09T05:00:00Z | 2023 | 3 | 2023-03-09T13:33:08Z | 0 | 0 | 0900006485779051 | |||
| FDA-2022-N-0002-0034 | FDA | None FDA-2022-N-0002 | FOI Summary sN 141-348 approved July 18, 2022 | Supporting & Related Material | Background Material | 2023-03-09T05:00:00Z | 2023 | 3 | 2023-03-09T13:33:43Z | 0 | 0 | 09000064857791a2 | |||
| FDA-2022-N-0002-0038 | FDA | None FDA-2022-N-0002 | FONSI sN 141-348 approved July 18, 2022 | Supporting & Related Material | Background Material | 2023-03-09T05:00:00Z | 2023 | 3 | 2023-03-09T13:34:52Z | 0 | 0 | 09000064857792f7 | |||
| FDA-2022-N-0002-0020 | FDA | None FDA-2022-N-0002 | EA sN 141-043 approved July 18, 2022 | Supporting & Related Material | Background Material | 2023-03-09T05:00:00Z | 2023 | 3 | 2023-03-09T13:30:40Z | 0 | 0 | 090000648577897b | |||
| FDA-2022-N-0002-0022 | FDA | None FDA-2022-N-0002 | FOI Summary oA 200-694 approved September 29, 2022 | Supporting & Related Material | Background Material | 2023-03-09T05:00:00Z | 2023 | 3 | 2023-03-09T13:30:54Z | 0 | 0 | 0900006485778963 | |||
| FDA-2022-N-0002-0023 | FDA | None FDA-2022-N-0002 | FOI Summary oA 200-719 approved September 28, 2022 | Supporting & Related Material | Background Material | 2023-03-09T05:00:00Z | 2023 | 3 | 2023-03-09T13:31:09Z | 0 | 0 | 0900006485778984 | |||
| FDA-2022-N-0002-0025 | FDA | None FDA-2022-N-0002 | FOI Summary oA 200-725 approved July 19, 2022 | Supporting & Related Material | Background Material | 2023-03-09T05:00:00Z | 2023 | 3 | 2023-03-09T13:31:28Z | 0 | 0 | 0900006485778e8a | |||
| FDA-2022-N-0002-0026 | FDA | None FDA-2022-N-0002 | FOI Summary oA 200-726 approved July 29, 2022 | Supporting & Related Material | Background Material | 2023-03-09T05:00:00Z | 2023 | 3 | 2023-03-09T13:31:48Z | 0 | 0 | 0900006485778e8b | |||
| FDA-2022-N-0002-0027 | FDA | None FDA-2022-N-0002 | FOI Summary oA 200-727 approved July 29, 2022 | Supporting & Related Material | Background Material | 2023-03-09T05:00:00Z | 2023 | 3 | 2023-03-09T13:32:10Z | 0 | 0 | 0900006485778e8c | |||
| FDA-2022-N-0002-0030 | FDA | None FDA-2022-N-0002 | FOI Summary oN 141-553 approved September 9, 2022 | Supporting & Related Material | Background Material | 2023-03-09T05:00:00Z | 2023 | 3 | 2023-03-09T13:32:40Z | 0 | 0 | 0900006485778e92 | |||
| FDA-2022-N-0002-0033 | FDA | None FDA-2022-N-0002 | FOI Summary sN 141-043 approved July 18, 2022 | Supporting & Related Material | Background Material | 2023-03-09T05:00:00Z | 2023 | 3 | 2023-03-09T13:33:22Z | 0 | 0 | 090000648577912c | |||
| FDA-2022-N-0002-0036 | FDA | None FDA-2022-N-0002 | FOI Summary sN 141-518 approved August 9, 2022 | Supporting & Related Material | Background Material | 2023-03-09T05:00:00Z | 2023 | 3 | 2023-03-09T13:34:21Z | 0 | 0 | 09000064857791a9 | |||
| FDA-2022-N-0002-0037 | FDA | None FDA-2022-N-0002 | FONSI sN 141-043 approved July 18, 2022 | Supporting & Related Material | Background Material | 2023-03-09T05:00:00Z | 2023 | 3 | 2023-03-09T13:34:41Z | 0 | 0 | 09000064857792f6 | |||
| FDA-2022-N-0002-0028 | FDA | None FDA-2022-N-0002 | FOI Summary oN 141-429 approved September 6, 2022 | Supporting & Related Material | Background Material | 2023-03-09T05:00:00Z | 2023 | 3 | 2023-03-09T13:32:18Z | 0 | 0 | 09000064857789d4 | |||
| FDA-2022-N-0002-0035 | FDA | None FDA-2022-N-0002 | FOI Summary sN 141-459 approved august 9, 2022 | Supporting & Related Material | Background Material | 2023-03-09T05:00:00Z | 2023 | 3 | 2023-03-09T13:34:08Z | 0 | 0 | 09000064857791a3 |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE documents (
id TEXT PRIMARY KEY,
agency_id TEXT,
docket_id TEXT REFERENCES dockets(id),
title TEXT,
document_type TEXT,
subtype TEXT,
posted_date TEXT,
posted_year INTEGER,
posted_month INTEGER,
comment_start_date TEXT,
comment_end_date TEXT,
last_modified TEXT,
fr_doc_num TEXT,
open_for_comment INTEGER,
withdrawn INTEGER,
object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);
CREATE INDEX idx_docs_comment_end ON documents(comment_end_date) WHERE comment_end_date IS NOT NULL AND withdrawn = 0;